UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

Medical mycology (Oxford), 2013-02, Vol.51 (2), p.150-154

2013

Volltextzugriff (PDF)

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA group

British journal of haematology, 2001-07, Vol.114 (1), p.99-103

2001

Volltextzugriff (PDF)

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Leukemia research, 2015-03, Vol.39 (3), p.296-306

2015

Volltextzugriff (PDF)

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

Annals of hematology, 2017-08, Vol.96 (8), p.1323-1330

2017

Volltextzugriff (PDF)

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Haematologica (Roma), 2011-10, Vol.96 (10), p.1470-1477

2011

Volltextzugriff (PDF)

Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia

Leukemia, 2001-12, Vol.15 (12), p.1999-1999

2001

Volltextzugriff (PDF)

Response to Lengfelder et al

Leukemia, 2001-12, Vol.15 (12), p.2001-2002

2001

Volltextzugriff (PDF)

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

Haematologica (Roma), 2009-09, Vol.94 (9), p.1242-1249

2009

Volltextzugriff (PDF)

Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP

Actas dermo-sifiliográficas, 2006-07, Vol.97 (6), p.385

2006

Volltextzugriff (PDF)

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Haematologica (Roma), 2010-04, Vol.95 (4), p.589-596

2010

Volltextzugriff (PDF)

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia

Blood, 1999-11, Vol.94 (9), p.3015-3021

1999

Volltextzugriff (PDF)

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

Blood, 2004-12, Vol.104 (12), p.3490-3493

2004

Volltextzugriff (PDF)

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Leukemia & lymphoma, 2019-09, Vol.60 (11), p.2720-2732

2019

Volltextzugriff (PDF)

Dos enfermedades relacionadas con el VHH-8 en un paciente VIH-negativo: sarcoma de Kaposi y enfermedad de Castleman multicéntrica. Respuesta a tratamiento con rituximab y CHOP

Actas dermo-sifiliográficas, 2006-07, Vol.97 (6), p.385-390

2006

Volltextzugriff (PDF)

Pancoast Syndrome and Endobronchial Tumor Infiltration as the First Manifestation of Hodgkin Lymphoma

Archivos de bronconeumología (English ed.), 2004-06, Vol.40 (6), p.287-289, Article 287

2004

Volltextzugriff (PDF)

Síndrome de Pancoast e infiltración tumoral endobronquial como primera manifestación de un linfoma de Hodgkin

Archivos de bronconeumología, 2004, Vol.40 (6), p.287-289

2004

Volltextzugriff (PDF)

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

Haematologica (Roma), 2005-10, Vol.90 (10), p.1346-1356

2005

Volltextzugriff (PDF)

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group

Blood, 1999-11, Vol.94 (9), p.3015

1999

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(92)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(38)
Humans
(37)
Male
(29)
Female
(28)
Middle Aged
(22)
Aged
(21)
Adult
(19)
Hematology
(18)
Adolescent
(13)
Biological And Medical Sciences
(13)
Physics Of Elementary Particles And Fields
(13)
Treatment Outcome
(12)
Medical Sciences
(11)
Physical Sciences
(11)
Hematologic And Hematopoietic Diseases
(10)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(10)
Applied Sciences
(9)
Exact Sciences And Technology
(9)
Risk Factors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study)

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML‐RARα isoforms: a study of the PETHEMA group

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

Response to Lengfelder et al

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study

Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

Dos enfermedades relacionadas con el VHH-8 en un paciente VIH-negativo: sarcoma de Kaposi y enfermedad de Castleman multicéntrica. Respuesta a tratamiento con rituximab y CHOP

Pancoast Syndrome and Endobronchial Tumor Infiltration as the First Manifestation of Hodgkin Lymphoma

Síndrome de Pancoast e infiltración tumoral endobronquial como primera manifestación de un linfoma de Hodgkin

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group

Identification of Neoplastic Infiltration of the Cerebrospinal Fluid (CSF) in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma (B-NHL) without Clinical Evidence of Leptomeningeal Disease: A Comparative Analysis of the Utility of Flow Cytometry (FCM) Versus Conventional Cytology (CC)

Suchergebnisse filtern